When a patient is diagnosed with osteosarcoma, an aggressive form of bone cancer, the mission is to remove the tumor entirely ...
Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India Diagnostic concordance was observed in 296 cases ...
A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, "Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma." Pazopanib, a multi-kinase ...
Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System Patients treated on regimen B did not have significantly better ...
Verywell Health on MSN
How serious is bone marrow edema and what causes it?
Medically reviewed by David Ozeri, MD Key Takeaways Bone marrow edema is caused by fluid buildup in bones due to injuries or ...
A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results